An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

NCT04442295 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Dravet Syndrome

Interventions

DRUG: STK-001 - Single Ascending Doses
DRUG: STK-001 - Multiple Ascending Doses

Sponsor

Stoke Therapeutics, Inc